CClinicalTrials.gg
Sign In
CompletedNCT03808415Updated Oct 21, 2022

CUHK Jockey Club HOPE 4 Care Programme - Hand of Hope

An interventional study of EMG-driven in Stroke, sponsored by Chinese University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-21.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
111
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The Hong Kong Jockey Club Charities Trust has supported CUHK to launch a three-year project 'CUHK Jockey Club HOPE4Care Programme' to implement four evidence-based advanced rehabilitation technologies in 40 local elderly day care centres and rehabilitation centres, to benefit the community.

The interactive intention-driven hand training robotic system is used for neuromuscular rehabilitation of the hand and forearm. This can help stroke survivors to regain their hand functions through motor relearning.

02

Conditions studied

  • Stroke

Browse trials for

03

In context

Stroke

7,283 studies on the registry are indexed under Stroke; 2,013 are open to participants now.

This study's enrollment of 111 is above the median of 50 across 5,366 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • at least six months after the onset of a unilateral ischemic brain injury or intracerebral haemorrhage
  • upper-limb motor impairments due to stroke
  • metacarpophalangeal and proximal interphalangeal joints of fingers can be extended to 180 degree passively
  • spasticity during extension at the finger joints is lower than 3 as measured by the Modified Ashworth Scale
  • detectable voluntary EMG signals from the flexor digitorum and extensor digitorum muscles of the paretic hand
  • have sufficient cognition to follow the experimental instructions

Exclusion criteria

Exclusion Criteria:

  • have other neurological, neuromuscular, and orthopedic diseases
  • have shoulder or arm contracture/pain
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
111 participants (actual)

Study arms

  • Experimental
    EMG-driven

    The hand training system functions as a biofeedback device which surface electromyography (EMG) sensors are used to capture the user's own muscle signals to activate the system for moving his/her paretic hand.

    Device: EMG-driven

Interventions

  • DeviceEMG-driven

    The EMG signals are processed and can be visualized with visual feedback to make sure the user actively engaging throughout a therapy session.

06

What researchers measure

Primary outcomes

  1. Action Research Arm Test (ARAT)

    Time frame: 3-month follow-up

  2. Fugl-Meyer Assessment Upper Extremity (FMA-UE)

    Time frame: 3-month follow-up

  3. Wolf Motor Function Test (WMFT)

    Time frame: 3-month follow-up

Secondary outcomes

  1. Modified Ashworth Scale (MAS)

    Time frame: 3-month follow-up

07

Study locations

1 site
  • Department of Biomedical Engineering, The Chinese University of Hong Kong
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03808415
Lead sponsor
Chinese University of Hong Kong
Collaborators
The Hong Kong Jockey Club Charities Trust
Responsible party
Raymond KY Tong (Professor and Chairman, Chinese University of Hong Kong) — Principal investigator
First posted
Jan 17, 2019
Start date
Feb 1, 2019
Primary completion
Jul 31, 2022
Completion
Jul 31, 2022
Last update
Oct 21, 2022

Study contacts

Raymond Tong, PhD
principal investigator · Department of Biomedical Engineering, CUHK

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Stroke→

Other studies from this sponsor

Chinese University of Hong Kong

Start the discussion